keyword
https://read.qxmd.com/read/36442221/a-shortcut-weighted-fusion-pyramid-network-for-microcalcification-detection-in-breast-mammograms
#1
JOURNAL ARTICLE
Huairui Zhao, Jia Hua, Xiaochuan Geng, Jianrong Xu, Yi Guo, Shiteng Suo, Yan Zhou, Yuanyuan Wang
BACKGROUND: High-precision detection for individual and clustered microcalcifications in mammograms is important for the early diagnosis of breast cancer. Large-scale differences between the two types and low-contrast images are major difficulties faced by radiologists when performing diagnoses. OBJECTIVE: Deep learning-based methods can provide end-to-end solutions for efficient detection. However, multicenter data bias, the low resolution of network inputs, and scale differences between microcalcifications lead to low detection rates...
November 17, 2022: Technology and Health Care: Official Journal of the European Society for Engineering and Medicine
https://read.qxmd.com/read/36442188/acute-inflammatory-response-to-multiple-chemotherapy-regimen-in-breast-carcinoma-an-unreported-entity1
#2
JOURNAL ARTICLE
Chandan Kumar Jha, Harshit Verma, Upasna Sinha, Prashant Kumar Singh
Increased utilization of chemotherapy in breast cancer patients has led to improved survival outcomes but it has also resulted in rising incidence of adverse effects. Occurrence of new/unreported side effect poses challenge in front of clinicians. We report the case of a 53-year lady with locally advanced, hormone receptor-positive, and human epidermal growth factor-2 (HER-2) negative right breast carcinoma. She was started on neoadjuvant chemotherapy (NACT) (doxorubicin and cyclophosphamide), to facilitate breast-conserving surgery...
2022: Breast Disease
https://read.qxmd.com/read/36442170/erbb4-encoded-novel-mirnas-act-as-tumor-suppressors-by-regulating-erbb-pi3k-signaling
#3
JOURNAL ARTICLE
Zahra Ghaemi, Bahram M Soltani, Seyed Javad Mowla
BACKGROUND: ErbB/PI3K signaling is widely recognized as a critical modulator of malignancy and miRNAs have been found to play a crucial role in the regulation of this pathway. OBJECTIVE: This study aimed to identify novel miRNAs related to the ErbBs loci and investigate the functional effects of these miRNAs on ErbB/PI3K signaling in cancer progression. MATERIALS AND METHODS: Bioinformatics tools and RNA-seq data were used to discover novel miRNAs in breast and colon cancer cells...
2022: Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine
https://read.qxmd.com/read/36442137/increase-of-atypical-fibroxanthoma-and-pleomorphic-dermal-sarcoma-a-retrospective-analysis-of-four-german-skin-cancer-centers
#4
JOURNAL ARTICLE
Thomas Kuntz, Julian Siebdrath, Silke C Hofmann, Mehmet Baltaci, Jörg Schaller, Martin Hellmich, Luise Stach von Goltzheim, Chalid Assaf, Frank Oellig, Alena-Lioba Michalowitz, Doris Helbig, Alexander Kreuter
BACKGROUND AND OBJECTIVES: In recent years, considerable insight has been gained into the pathogenesis, diagnosis and treatment of cutaneous sarcomas, including atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). Both entities have shown increasing incidence rates in the last decade. This study was initiated to evaluate how these new insights impact the number of diagnoses of AFX/PDS compared to other cutaneous sarcoma entities. PATIENTS AND METHODS: In a retrospective study of four German skin cancer centers, all histopathological reports of cutaneous sarcomas (AFX, PDS, dermatofibrosarcoma protuberans, cutaneous leiomyosarcoma, angiosarcoma, and Kaposi sarcoma) confirmed by board-certified dermatopathologists were analyzed during a time-period of seven years (2013-2019)...
November 28, 2022: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/36442099/tumor-targeted-delivery-of-a-sting-agonist-improvescancer-immunotherapy
#5
JOURNAL ARTICLE
You-Tong Wu, Yan Fang, Qi Wei, Heping Shi, Huiling Tan, Yafang Deng, Zhiqun Zeng, Jian Qiu, Chuo Chen, Lijun Sun, Zhijian J Chen
The cGAS-STING pathway is essential for immune defense against microbial pathogens and malignant cells; as such, STING is an attractive target for cancer immunotherapy. However, systemic administration of STING agonists poses safety issues while intratumoral injection is limited by tumor accessibility. Here, we generated antibody-drug conjugates (ADCs) by conjugating a STING agonist through a cleavable linker to antibodies targeting tumor cells. Systemic administration of these ADCs was well tolerated and exhibited potent antitumor efficacy in syngeneic mouse tumor models...
December 6, 2022: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/36442096/human-t-cells-recognize-hla-dp-bound-peptides-in-two%C3%A2-orientations
#6
JOURNAL ARTICLE
Sebastian Klobuch, Jia Jia Lim, Peter van Balen, Michel G D Kester, Wendy de Klerk, Arnoud H de Ru, Cilia R Pothast, Inge Jedema, Jan W Drijfhout, Jamie Rossjohn, Hugh H Reid, Peter A van Veelen, J H Frederik Falkenburg, Mirjam H M Heemskerk
Human leukocyte antigen (HLA) molecules present small peptide antigens to T cells, thereby allowing them to recognize pathogen-infected and cancer cells. A central dogma over the last 50+ y is that peptide binding to HLA molecules is mediated by the docking of side chains of particular amino acids in the peptide into pockets in the HLA molecules in a conserved N- to C-terminal orientation. Whether peptides can be presented in a reversed C- to N-terminal orientation remains unclear. Here, we performed large-scale identification of peptides bound to HLA-DP molecules and observed that in addition to peptide binding in an N- to C-terminal orientation, in 9 out of 14 HLA-DP allotypes, reverse motifs are found, compatible with C- to N-terminal peptide binding...
December 6, 2022: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/36442087/transcriptome-based-molecular-subtypes-and-differentiation-hierarchies-improve-the-classification-framework-of-acute-myeloid-leukemia
#7
JOURNAL ARTICLE
Wen-Yan Cheng, Jian-Feng Li, Yong-Mei Zhu, Xiang-Jie Lin, Li-Jun Wen, Fan Zhang, Yu-Liang Zhang, Ming Zhao, Hai Fang, Sheng-Yue Wang, Xiao-Jing Lin, Niu Qiao, Wei Yin, Jia-Nan Zhang, Yu-Ting Dai, Lu Jiang, Xiao-Jian Sun, Yi Xu, Tong-Tong Zhang, Su-Ning Chen, Hong-Hu Zhu, Zhu Chen, Jie Jin, De-Pei Wu, Yang Shen, Sai-Juan Chen
The current classification of acute myeloid leukemia (AML) relies largely on genomic alterations. Robust identification of clinically and biologically relevant molecular subtypes from nongenomic high-throughput sequencing data remains challenging. We established the largest multicenter AML cohort (n = 655) in China, with all patients subjected to RNA sequencing (RNA-Seq) and 619 (94.5%) to targeted or whole-exome sequencing (TES/WES). Based on an enhanced consensus clustering, eight stable gene expression subgroups (G1-G8) with unique clinical and biological significance were identified, including two unreported (G5 and G8) and three redefined ones (G4, G6, and G7)...
December 6, 2022: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/36442077/iron-oxide-nanoparticles-decorated-with-functional-peptides-for-a-targeted-sirna-delivery-to-glioma-cells
#8
REVIEW
Seokhwan Chung, Yutaro Sugimoto, Jianxi Huang, Miqin Zhang
Glioma is a deadly form of brain cancer, and the difficulty of treating glioma is exacerbated by the chemotherapeutic resistance developed in the tumor cells over the time of treatment. siRNA can be used to silence the gene responsible for the increased resistance, and sensitize the glioma cells to drugs. Here, iron oxide nanoparticles functionalized with peptides (NP-CTX-R10 ) were used to deliver siRNA to silence O6-methylguanine-DNA methyltransferase (MGMT) to sensitize tumor cells to alkylating drug, Temozolomide (TMZ)...
November 28, 2022: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/36442073/cancer-screening-in-prisons-lessons-for-health-providers
#9
JOURNAL ARTICLE
Sarah Hesse, Kim Williamson, Deborah Bonney, Marie Finley, Tom Meehan
BACKGROUND: Lifestyle factors place those who experience incarceration at increased risk of morbidity and mortality from a range of preventable diseases, including cancer. METHODS: Two nurses were employed for a period of 6months to facilitate bowel and breast cancer screening of prisoners across four correctional centres in Queensland. We identify factors impacting on cancer screening in prisons and document the outcomes for those screened. RESULTS: Both screening programs produced a positivity rate of ∼17% in those screened, with 23 individuals returning a positive faecal occult blood test and five women requiring further investigations following breast screening...
November 29, 2022: Australian Journal of Primary Health
https://read.qxmd.com/read/36442059/major-update-2-antibody-response-and-risk-for-reinfection-after-sars-cov-2-infection-final-update-of-a-living-rapid-review
#10
REVIEW
Haley K Holmer, Katherine Mackey, Celia V Fiordalisi, Mark Helfand
BACKGROUND: The durability of the antibody response after SARS-CoV-2 infection and the role of antibodies in protection against reinfection are unclear. PURPOSE: To synthesize evidence on the SARS-CoV-2 antibody response and reinfection risk with a focus on gaps identified in our prior reports. DATA SOURCES: MEDLINE (Ovid), EMBASE, CINAHL, World Health Organization Research Database, and reference lists from 16 December 2021 through 8 July 2022, with surveillance through 22 August 2022...
November 29, 2022: Annals of Internal Medicine
https://read.qxmd.com/read/36441987/state-variation-in-squamous-cell-carcinoma-of-the-anus-incidence-and-mortality-and-association-with-hiv-aids-and-smoking-in-the-united-states
#11
JOURNAL ARTICLE
Haluk Damgacioglu, Yueh-Yun Lin, Ana Patricia Ortiz, Chi-Fang Wu, Zahed Shahmoradi, Shiang Shiuan Shyu, Ruosha Li, Alan G Nyitray, Keith Sigel, Gary M Clifford, Naomi Jay, Vivian Colon Lopez, Gregory M Barnell, Elizabeth Y Chiao, Elizabeth A Stier, Karen J Ortiz-Ortiz, Jeslie M Ramos-Cartagena, Kalyani Sonawane, Ashish A Deshmukh
PURPOSE: Squamous cell carcinoma of the anus (SCCA) incidence and mortality rates are rising in the United States. Understanding state-level incidence and mortality patterns and associations with smoking and AIDS prevalence (key risk factors) could help unravel disparities and provide etiologic clues. METHODS: Using the US Cancer Statistics and the National Center for Health Statistics data sets, we estimated state-level SCCA incidence and mortality rates. Rate ratios (RRs) were calculated to compare incidence and mortality in 2014-2018 versus 2001-2005...
November 28, 2022: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://read.qxmd.com/read/36441908/dna-dendrimer-based-directed-3d-walking-nanomachine-for-the-sensitive-detection-and-intracellular-imaging-of-mirna
#12
JOURNAL ARTICLE
Xing Wang, Hongzhi Sun, Bojun Liu, Kemei Jiang, Zhaohui Li, Hong-Min Meng
Taking advantage of the remarkable processivity and membrane penetrability, the gold nanoparticle (AuNP)-based three-dimensional (3D) DNA walking nanomachine has induced tremendous promise in molecular diagnostics and cancer therapy, whereas the executive ability of this nanomachine was eventually limited because of the disordered assembly between the walker and the track. Therefore, we developed a well-directed 3D DNA walking nanomachine by employing a DNA dendrimer as the track for intracellular imaging with high directionality and controllability...
November 28, 2022: Analytical Chemistry
https://read.qxmd.com/read/36441901/tumor-microenvironment-activable-manganese-boosted-catalytic-immunotherapy-combined-with-pd-1-checkpoint-blockade
#13
JOURNAL ARTICLE
Zhiyu Zhao, Shuming Dong, Yue Liu, Jianxin Wang, Li Ba, Cong Zhang, Xinyu Cao, Changjun Wu, Piaoping Yang
Immune checkpoint blockade (ICB) therapy has attracted widespread attention in cancer treatment. Due to the low immunogenicity and immune suppression state in the tumor microenvironment (TME), the therapeutic effects are only moderate. Herein, a TME-activable manganese-boosted catalytic immunotherapy is designed for synergism with ICB therapy to kill tumors efficiently. The tumor cell membrane (CM)-wrapping multienzyme-mimic manganese oxide (MnO x ) nanozyme termed [email protected] showed intrinsic peroxidase and oxidase-like activities in an acidic TME...
November 28, 2022: ACS Nano
https://read.qxmd.com/read/36441842/a-virus-changed-my-life
#14
JOURNAL ARTICLE
Renato J Aguilera
The E. E. Just Award commemorates the great African-American cell biologist Dr. Ernest Everett Just, who was a successful pioneer in an era of systemic exclusion of minorities in science and academia. Receiving this award is not only an honor but a recognition of my long-standing commitment to helping Persons Excluded due to Ethnicity or Race (PEERS) to achieve success in biomedical careers. As a proud member of this group, I have devoted most of my career to training underrepresented undergraduate and graduate students to pursue scientific careers...
December 1, 2022: Molecular Biology of the Cell
https://read.qxmd.com/read/36441840/anti-pd-1-checkpoint-inhibitor-as-a-first-line-treatment-for-advanced-cutaneous-squamous-cell-carcinoma
#15
JOURNAL ARTICLE
Katerina Bopota, Oliver Donnelly, Farzad Borumandi
Immune checkpoint inhibitors (ICI) have become an essential part of cancer treatment. Anti-programmed cell death receptor-1 (PD-1) is a monoclonal antibody that targets PD-1. For patients with inoperable cutaneous squamous cell carcinoma, anti-PD-1 ICI treatment has been approved as monotherapy or in adjunct with other treatment modalities. A patient primarily treated with PD-1 inhibition for local advanced moderately differentiated cutaneous squamous cell carcinoma involving the parotid and the neck is presented...
November 1, 2022: Journal of Craniofacial Surgery
https://read.qxmd.com/read/36441800/therapeutic-targeting-of-lif-overcomes-macrophage-mediated-immunosuppression-of-the-local-tumor-microenvironment
#16
JOURNAL ARTICLE
Robin Hallett, Ester Bonfill-Teixidor, Raffaella Iurlaro, Alexandra Arias, Swetha Raman, Peter E Bayliss, Olga Egorova, Almudena Neva-Alejo, Aj Robert McGray, Esther Lau, Alexandre Bosch, Melissa Beilschmidt, Dorothea Maetzel, Johan Fransson, Isabel Huber-Ruano, Judit Anido, Jean-Philippe Julien, Patricia A Giblin, Joan Seoane
PURPOSE: Leukemia inhibitory factor (LIF) is a multifunctional cytokine with numerous reported roles in cancer and is thought to drive tumor development and progression. Characterization of LIF and clinical-stage LIF inhibitors would increase our understanding of LIF as a therapeutic target. EXPERIMENTAL DESIGN: We first tested the association of LIF expression with transcript signatures representing multiple processes regulating tumor development and progression...
November 28, 2022: Clinical Cancer Research
https://read.qxmd.com/read/36441798/impact-of-rna-signatures-on-pcr-and-survival-after-12-week-neoadjuvant-pertuzumab-plus-trastuzumab-with-or-without-paclitaxel-in-the-wsg-adapt-her2-hr-trial
#17
JOURNAL ARTICLE
Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, Sherko Kuemmel, Eva-Maria Grischke, Doris Augustin, Michael Braun, Jochem Potenberg, Rachel Wuerstlein, Katja Krauss, Claudia Schumacher, Helmut Forstbauer, Toralf Reimer, Andrea Stefek, Hans Holger Fischer, Enrico Pelz, Christine Zu Eulenburg, Ronald Kates, Hua Ni, Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Hans Heinrich Kreipe, Ulrike Nitz, Nadia Harbeck
PURPOSE: TTo identify associations of biological signatures and stromal tumor infiltrating lymphocytes (sTILs) with pathological complete response (pCR, ypT0 ypN0) and survival in the phase II WSG-ADAPT HER2+/HR- trial (NCT01817452). EXPERIMENTAL DESIGN: Patients with cT1-cT4c, cN0-3 HER2+/HR- early breast cancer (EBC) were randomized to pertuzumab+trastuzumab (P+T, n=92) or P+T+paclitaxel (n=42). Gene expression signatures were analyzed in baseline (BL) biopsies using NanoString Breast Cancer 360 panel (n=117); BL and on-treatment (week 3) sTIL levels were available in 119 and 76 patients, respectively...
November 28, 2022: Clinical Cancer Research
https://read.qxmd.com/read/36441795/-18f-fluorthanatrace-18f-ftt-pet-imaging-of-parp-inhibitor-drug-target-engagement-as-a-biomarker-of-response-in-ovarian-cancer-a-pilot-study
#18
JOURNAL ARTICLE
Austin R Pantel, Sarah B Gitto, Mehran Makvandi, Hyoung Kim, Sergey Medvedv, Joanna K Weeks, Drew A Torigian, Chia-Ju Hsieh, Benjamin Ferman, Nawar A Latif, Janos L Tanyi, Lainie P Martin, Shannon M Lanzo, Fang Liu, Quy Cao, Gordon B Mills, Robert K Doot, David A Mankoff, Robert H Mach, Lilie L Lin, Fiona Simpkins
PURPOSE: Poly(ADP-ribose) polymerase enzyme inhibitors (PARPi) have become the standard-of-care treatment for homologous recombination deficient (HRD) high-grade serous ovarian cancer (HGSOC). However, not all HRD tumors respond to PARPi. Biomarkers to predict response are needed. [18F]FluorThanatrace ([18F]FTT) is a PARPi-analog PET radiotracer that non-invasively measures PARP-1 expression. Herein, we evaluate [18F]FTT as a biomarker to predict response to PARPi in patient-derived xenograft (PDX) models and subjects with HRD HGSOC...
November 28, 2022: Clinical Cancer Research
https://read.qxmd.com/read/36441784/essential-amino-acids-as-diagnostic-biomarkers-of-hepatocellular-carcinoma-based-on-metabolic-analysis
#19
JOURNAL ARTICLE
Yuji Morine, Tohru Utsunomiya, Hisami Yamanaka-Okumura, Yu Saito, Shinichiro Yamada, Tetsuya Ikemoto, Satoru Imura, Shohei Kinoshita, Akiyoshi Hirayama, Yasuhito Tanaka, Mitsuo Shimada
Metabolomics, defined as the comprehensive identification of all small metabolites in a biological sample, has the power to shed light on phenotypic changes associated with various diseases, including cancer. To discover potential metabolomic biomarkers of hepatocellular carcinoma (HCC), we investigated the metabolomes of tumor and non-tumor tissue in 20 patients with primary HCC using capillary electrophoresis-time-of-flight mass spectrometry. We also analyzed blood samples taken immediately before and 14 days after hepatectomy to identify associated changes in the serum metabolome...
November 22, 2022: Oncotarget
https://read.qxmd.com/read/36441776/a-multicenter-randomized-single-blind-2-arm-intervention-study-evaluating-the-adverse-events-and-quality-of-life-after-irreversible-electroporation-for-the-ablation-of-localized-low-intermediate-risk-prostate-cancer
#20
JOURNAL ARTICLE
Jean de la Rosette, Jose Dominguez-Escrig, Kai Zhang, Jeremy Teoh, Eric Barret, Juan Casanova Ramon-Borja, Gordon Muir, Julia Bohr, Theo de Reijke, Chi-Fai Ng, Chi-Ho Leung, Rafael Sanchez-Salas, Pilar Laguna
PURPOSE: Our goal was to evaluate the effect of focal vs extended irreversible electroporation on side effects, patient-reported quality of life, and early oncologic control for localized low-intermediate risk prostate cancer patients. MATERIALS AND METHODS: Men with localized low-intermediate risk prostate cancer were randomized to receive focal or extended irreversible electroporation ablation. Quality of life was measured by International Index of Erectile Function, Expanded Prostate Cancer Index Composite questionnaire, and International Prostate Symptom Score...
November 28, 2022: Journal of Urology
keyword
keyword
302
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.